|
|
indium In 111 ibritumomab tiuxetan A targeted radioimmunoconjugate composed of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by a chelator (tiuxetan) to the imaging radioisotope indium-111. This radioimmunoconjugate binds to CD20-positive cells, permitting radioimmuno-localization of CD20-positive cell biodistribution. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name: | | IDEC-In2B8 | | |
|
|